Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beyond Air ( (XAIR) ) has provided an update.
On April 7, 2026, Beyond Air disclosed that it received notice from Nasdaq that its common stock no longer meets the $1.00 minimum bid price requirement for continued listing, after trading below that threshold for 30 consecutive business days from February 23 to April 6, 2026. Because the company carried out a 1-for-20 reverse stock split on July 14, 2025, it is not eligible for the usual 180-day cure period, and its securities are subject to potential delisting unless it requests a hearing by April 14, 2026.
Beyond Air plans to request a hearing before a Nasdaq Hearings Panel, which would automatically stay any suspension or delisting action while the appeal is pending and allow the stock to continue trading. The company is monitoring its share price and evaluating options, including another reverse stock split, but there is no assurance it will regain compliance or secure continued listing, leaving shareholders exposed to the risk of a Nasdaq delisting and possible migration to a less liquid trading venue.
The most recent analyst rating on (XAIR) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on Beyond Air stock, see the XAIR Stock Forecast page.
Spark’s Take on XAIR Stock
According to Spark, TipRanks’ AI Analyst, XAIR is a Neutral.
The score is held down primarily by weak financial performance (large ongoing losses, heavy cash burn, and a weakened balance sheet despite improving revenue) and bearish technicals (price below key moving averages with negative MACD). Partially offsetting these are constructive earnings-call signals around accelerating revenue growth, improved gross profit and reduced cash burn, while valuation inputs are mixed due to a negative P/E and no dividend data.
To see Spark’s full report on XAIR stock, click here.
More about Beyond Air
Beyond Air, Inc. operates in the healthcare and biopharmaceutical sector, focusing on the development and commercialization of medical technologies and therapies. The company’s shares are listed on the Nasdaq Stock Market, providing it access to public equity capital and visibility among institutional and retail investors.
Average Trading Volume: 7,544,337
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.5M
For a thorough assessment of XAIR stock, go to TipRanks’ Stock Analysis page.